These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17270346)

  • 21. Desensitized nicotinic receptors in brain.
    Wang H; Sun X
    Brain Res Brain Res Rev; 2005 Jun; 48(3):420-37. PubMed ID: 15914250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intermittent L-DOPA treatment differentially alters synaptotagmin 4 and 7 gene expression in the striatum of hemiparkinsonian rats.
    Glavan G
    Brain Res; 2008 Oct; 1236():216-24. PubMed ID: 18721798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests.
    Andreasen JT; Olsen GM; Wiborg O; Redrobe JP
    J Psychopharmacol; 2009 Sep; 23(7):797-804. PubMed ID: 18583432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive allosteric modulation of α4β2 nAChR agonist induced behaviour.
    Rode F; Munro G; Holst D; Nielsen EØ; Troelsen KB; Timmermann DB; Rønn LC; Grunnet M
    Brain Res; 2012 Jun; 1458():67-75. PubMed ID: 22552114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives: implications for Parkinson's Disease.
    Abin-Carriquiry JA; Costa G; Urbanavicius J; Cassels BK; Rebolledo-Fuentes M; Wonnacott S; Dajas F
    Eur J Pharmacol; 2008 Jul; 589(1-3):80-4. PubMed ID: 18589414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrastriatal botulinum toxin abolishes pathologic rotational behaviour and induces axonal varicosities in the 6-OHDA rat model of Parkinson's disease.
    Wree A; Mix E; Hawlitschka A; Antipova V; Witt M; Schmitt O; Benecke R
    Neurobiol Dis; 2011 Feb; 41(2):291-8. PubMed ID: 20955797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of caffeine against neurodegeneration in a model of Parkinson's disease in rat: behavioral and histochemical evidence.
    Joghataie MT; Roghani M; Negahdar F; Hashemi L
    Parkinsonism Relat Disord; 2004 Dec; 10(8):465-8. PubMed ID: 15542005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemiparkinsonian rats rotate toward the side with the weaker dopaminergic neurotransmission.
    Da Cunha C; Wietzikoski EC; Ferro MM; Martinez GR; Vital MA; Hipólide D; Tufik S; Canteras NS
    Behav Brain Res; 2008 Jun; 189(2):364-72. PubMed ID: 18328580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
    Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M
    Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of dorsal hippocampal nicotinic receptors in the effect of morphine on memory retrieval in passive avoidance task.
    Khajehpour L; Rezayof A; Zarrindast MR
    Eur J Pharmacol; 2008 Apr; 584(2-3):343-51. PubMed ID: 18316071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicotinic receptor-mediated reduction in L-DOPA-induced dyskinesias may occur via desensitization.
    Bordia T; Campos C; McIntosh JM; Quik M
    J Pharmacol Exp Ther; 2010 Jun; 333(3):929-38. PubMed ID: 20200117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term exposure to nicotine markedly reduces kynurenic acid in rat brain--in vitro and ex vivo evidence.
    Zielińska E; Kuc D; Zgrajka W; Turski WA; Dekundy A
    Toxicol Appl Pharmacol; 2009 Oct; 240(2):174-9. PubMed ID: 19616570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time-course gait analysis of hemiparkinsonian rats following 6-hydroxydopamine lesion.
    Hsieh TH; Chen JJ; Chen LH; Chiang PT; Lee HY
    Behav Brain Res; 2011 Sep; 222(1):1-9. PubMed ID: 21435355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electro-acupuncture stimulation improves motor disorders in Parkinsonian rats.
    Jia J; Sun Z; Li B; Pan Y; Wang H; Wang X; Yu F; Liu L; Zhang L; Wang X
    Behav Brain Res; 2009 Dec; 205(1):214-8. PubMed ID: 19549545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3-[(2,4-Dimethoxy)benzylidene]-anabaseine dihydrochloride protects against 6-hydroxydopamine-induced parkinsonian neurodegeneration through α7 nicotinic acetylcholine receptor stimulation in rats.
    Suzuki S; Kawamata J; Matsushita T; Matsumura A; Hisahara S; Takata K; Kitamura Y; Kem W; Shimohama S
    J Neurosci Res; 2013 Mar; 91(3):462-71. PubMed ID: 23239187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonmotor symptoms in Parkinson's disease: investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model.
    Branchi I; D'Andrea I; Armida M; Cassano T; Pèzzola A; Potenza RL; Morgese MG; Popoli P; Alleva E
    J Neurosci Res; 2008 Jul; 86(9):2050-61. PubMed ID: 18335518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nicotinic receptor inactivation after acute and repeated in vivo nicotine exposures in rats.
    Vann RE; James JR; Rosecrans JA; Robinson SE
    Brain Res; 2006 May; 1086(1):98-103. PubMed ID: 16626643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neonatal nicotine exposure impairs nicotinic enhancement of central auditory processing and auditory learning in adult rats.
    Liang K; Poytress BS; Chen Y; Leslie FM; Weinberger NM; Metherate R
    Eur J Neurosci; 2006 Aug; 24(3):857-66. PubMed ID: 16848798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms.
    Giorgi M; D'Angelo V; Esposito Z; Nuccetelli V; Sorge R; Martorana A; Stefani A; Bernardi G; Sancesario G
    Eur J Neurosci; 2008 Sep; 28(5):941-50. PubMed ID: 18717735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice.
    Ryan RE; Ross SA; Drago J; Loiacono RE
    Br J Pharmacol; 2001 Apr; 132(8):1650-6. PubMed ID: 11309235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.